ESC 365 - A systematic review of lipoprotein(a) reporting in Australia: variability in availability, measurement, and clinical recommendations

ESC2025 Premium Access

A systematic review of lipoprotein(a) reporting in Australia: variability in availability, measurement, and clinical recommendations

Session: Lipoprotein(a) (2)

Topic: Lipids

Speaker: Doctor R. Ma (Melbourne, AU)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Runqi Ma

The Alfred Hospital, Melbourne (Australia)

0 follower

5 more presentations in this session

Lipoprotein(a) levels in children with suspected familial hypercholesterolaemia identified through universal lipid screening: association with pathogenic variants

Speaker: Doctor R. Tani (Kagawa, JP)

Apolipoprotein B/LDL-C discordance and lipoprotein(a) as predictors of ASCVD risk in genetically confirmed heterozygous familial hypercholesterolemia (HeFH): A Retrospective Cohort Study (2005–2023)

Speaker: Doctor N. Genedy (Cardiff, GB) Doctor S. Zouwail (Cardiff, GB)

Comparison of lipoprotein (a) levels in patients with a history of coronary artery disease and in normal subjects

Speaker: Doctor T. Okada (Takamatsu, JP)

Lipoprotein(a) testing in Norway: trends and perspectives from primary care

Speaker: Ms J. Jeevanathan (Oslo, NO)

Variability of lipoprotein(a) concentrations in a cohort of patients enrolled in a cardiac rehabilitation program after an acute coronary syndrome

Speaker: Ms A. Diaz Rojo (Toledo, ES)

Access the full session

Lipoprotein(a) (2)

Speakers: Doctor R. Ma, Doctor R. Tani, Doctor N. Genedy, Doctor S. Zouwail, Doctor T. Okada...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources